A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Doxacurium
Danaparoid
The risk or severity of bleeding and bruising can be increased when Danaparoid is combined with Obeticholic acid.
Doxacurium
Dabigatran etexilate
The risk or severity of bleeding and bruising can be increased when Dabigatran etexilate is combined with Obeticholic acid.
Doxacurium
Amediplase
The risk or severity of bleeding and bruising can be increased when Amediplase is combined with Obeticholic acid.
Doxacurium
Otamixaban
The risk or severity of bleeding and bruising can be increased when Otamixaban is combined with Obeticholic acid.
Doxacurium
Apixaban
The risk or severity of bleeding and bruising can be increased when Apixaban is combined with Obeticholic acid.
Doxacurium
Astaxanthin
The risk or severity of bleeding and bruising can be increased when Astaxanthin is combined with Obeticholic acid.
Doxacurium
Idraparinux
The risk or severity of bleeding and bruising can be increased when Idraparinux is combined with Obeticholic acid.
Doxacurium
Semuloparin
The risk or severity of bleeding and bruising can be increased when Semuloparin is combined with Obeticholic acid.
Doxacurium
Sulodexide
The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Obeticholic acid.
Doxacurium
Rivaroxaban
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Obeticholic acid.
Doxacurium
Fibrinolysin
The risk or severity of bleeding and bruising can be increased when Fibrinolysin is combined with Obeticholic acid.
Doxacurium
Ancrod
The risk or severity of bleeding and bruising can be increased when Ancrod is combined with Obeticholic acid.
Doxacurium
Desmoteplase
The risk or severity of bleeding and bruising can be increased when Desmoteplase is combined with Obeticholic acid.
Doxacurium
Ximelagatran
The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Obeticholic acid.
Doxacurium
Coumarin
The risk or severity of bleeding and bruising can be increased when Coumarin is combined with Obeticholic acid.
Doxacurium
4-hydroxycoumarin
The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Obeticholic acid.
Doxacurium
Enoxaparin
The risk or severity of bleeding and bruising can be increased when Enoxaparin is combined with Obeticholic acid.
Desoxycorticosterone pivalate
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Dovitinib.
Desoxycorticosterone pivalate
Ozanimod
Dovitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Desoxycorticosterone pivalate
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Dovitinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3